Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Stem Cell Research

Free Subscription Articles published in Leuk Lymphoma Retrieve available abstracts of 43 articles: HTML format Text format

Single Articles

March 2010
1. GRIGG AP , Stone J, Milner AD, Schwarer AP, et al
   Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma.
   Leuk Lymphoma. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. LEUPIN N , Schuller JC, Solenthaler M, Heim D, et al
   Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02).
   Leuk Lymphoma. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. TADMOR T , Polliack A, Tam CS
   The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia: are all purine analogs created equal?
   Leuk Lymphoma. 2010.
   PubMed     Text format     Related articles   
   
   
   
4. OLTEANU H , Schur BC, Bredeson C, Atallah E, et al
   Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy.
   Leuk Lymphoma. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. ALOUSI AM , Uberti J, Ratanatharathorn V
   The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant.
   Leuk Lymphoma. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
6. SHI-XIA X , Xian-Hua T, Hai-Qin X, Bo F, et al
   Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis.
   Leuk Lymphoma. 2010;51:50-60.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
7. BENSON DM , Panzner K, Hamadani M, Hofmeister CC, et al
   Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma.
   Leuk Lymphoma. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. CORSO A , Barbarano L, Mangiacavalli S, Spriano M, et al
   Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma.
   Leuk Lymphoma. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. DOTI CA , Bullorsky EO
   Hematopoietic stem cell transplantation in the era of tyrosine kinase inhibitors.
   Leuk Lymphoma. 2009;50 Suppl 2:27-31.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
10. GRIGOLEIT GU , Kapp M, Tan SM, Unzicker C, et al
    Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case series.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles   
    
    
    October 2009
11. PATIL S , Spencer A, Schwarer A, Avery S, et al
    Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell t
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. JOACHIM DEEG H , Spaulding E, Shulman HM
    Iron overload, hematopoietic cell transplantation, and graft-versus-host disease.
    Leuk Lymphoma. 2009;50:1566-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. SCHMIDT-HIEBER M , Stroux A, Thiel E, Blau IW, et al
    Antibacterial prophylaxis with levofloxacin in patients after allogeneic stem cell transplantation and neutrophil reconstitution: results from a double-blinded, placebo-controlled phase III trial and overview of recent clinical practice.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles   
    
    
    September 2009
14. CAVATTONI I , Zabelina T, Ayuk F, Wolschke C, et al
    Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles   
    
    
    
15. LU Y , Huang Q
    Primary myelofibrosis relapsed with duodenal myeloid sarcoma after allogeneic stem cell transplantation.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles   
    
    
    
16. WANG HX , Yan HM, Liu J, Duan LN, et al
    Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement.
    Leuk Lymphoma. 2009;50:1488-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
17. SHIMONI A , Nagler A
    Stem-cell dose for allogeneic hematopoietic stem cell transplantation in hematological malignancies: is more better?
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles   
    
    
    
18. SMITH SD , Bolwell BJ, Advani AS, Andresen SW, et al
    High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
19. BURZYNSKI JA , Toro JJ, Patel RC, Lee S, et al
    Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. VOSE JM , Ho AD, Coiffier B, Corradini P, et al
    Advances in mobilization for the optimization of autologous stem cell transplantation.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. MEHTA J , Frankfurt O, Altman J, Evens A, et al
    Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. JANIKOVA A , Mayer J, Kren L, Smardova J, et al
    The persistence of t(14;18)-bearing cells in lymph nodes of patients with follicular lymphoma in complete remission: the evidence for 'a lymphoma stem cell'.
    Leuk Lymphoma. 2009;50:1102-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. KHAW SL , Huang DC, Roberts AW
    BH3-mimetics--the solution to chemoresistance?
    Leuk Lymphoma. 2009;50:1069-72.
    PubMed     Text format     Related articles   
    
    
    
24. KATZ BZ , Tavor S
    The stromal derived factor-1\CXCR4 axis--a legitimate therapeutic target in multiple myeloma?
    Leuk Lymphoma. 2009;50:1067-8.
    PubMed     Text format     Related articles   
    
    
    June 2009
25. TAM CS , Khouri IF
    Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphoma.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. STEWART DA , Bahis N, Mansoor A
    pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. REDDY KS , Schwartz GE, Jamedhor M
    A fertile XY/XX chimeric male with chronic myeloid leukemia in a minor 46,XX cell line and a history of polycythemia vera and trisomy 9 in the major 46,XY cell line.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles   
    
    
    
28. AU WY , Wong KY, Wan TS, So JC, et al
    A unique case of B cell lymphoma relapsing as CD4/CD56 blastic neoplasm.
    Leuk Lymphoma. 2009;50:932-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
29. SCHEELE JS , Kolanczyk M, Gantert M, Zemojtel T, et al
    The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1.
    Leuk Lymphoma. 2009;50:816-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
30. GANOR Y , Grinberg I, Reis A, Cooper I, et al
    Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. PHILLIPS AA , Willim RD, Savage DG, Horwitz SM, et al
    A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles   
    
    
    
32. OCHENI S , Iwanski GB, Schafhausen P, Zander AR, et al
    Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.
    Leuk Lymphoma. 2009;50:551-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. SEVILLA DW , Emmons FN, Bai X, Colovai A, et al
    The pattern of cytoplasmic IgM expression in the context of the three currently recognised maturational stages of hematogones.
    Leuk Lymphoma. 2009;50:642-4.
    PubMed     Text format     Related articles   
    
    
    
34. KALFF A , Juneja S
    B-acute leukemic lymphoblasts versus hematogones: the wolf in sheep's clothing/.
    Leuk Lymphoma. 2009;50:523-4.
    PubMed     Text format     Related articles   
    
    
    March 2009
35. COSTA LJ , Kumar S, Dispenzieri A, Hayman SE, et al
    Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. OCHENI S , Zabelina T, Bacher U, Ayuk F, et al
    Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
37. PAPADAKIS V , Karakasis D, Sfikakis PP, Baltadakis I, et al
    Is imatinib mesylate a promising drug in scleroderma due to extensive chronic graft-versus-host disease?
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles   
    
    
    
38. BLANES M , de la Rubia J, Lahuerta JJ, Gonzalez JD, et al
    Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. EVE HE , Seymour JF, Rule SA
    Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles   
    
    
    January 2009
40. POIRE X , Artz A, Larson RA, Kline J, et al
    Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
    Leuk Lymphoma. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. STIFF PJ
    Managing hematopoietic stem-cell transplant resources: the case for outpatient transplantation.
    Leuk Lymphoma. 2009;50:6-7.
    PubMed     Text format     Related articles   
    
    
    
42. MEHTA J , Dulley FL
    Outpatient or inpatient stem cell transplantation: patria est ubicunque est bene?
    Leuk Lymphoma. 2009;50:3-5.
    PubMed     Text format     Related articles   
    
    
    December 2008
43. WANG JC , Chen C, Dumlao T, Naik S, et al
    Enhanced histone deacetylase enzyme activity in primary myelofibrosis.
    Leuk Lymphoma. 2008;49:2321-7.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: